The document describes the features and advantages of a monolithic flip chip thyristor surge protection device array for implantable applications. This product offers significant advantages over the competition in terms of real estate reduction, on-state dissipation, switching characteristics, surge handling capability, and custom design options.
The TVSMEDA series offers monolithic flip‑chip thyristor surge protection device arrays designed for implantable applications. All contacts are on a single side, and the devices are available with a solderable surface and common anode/cathode configurations.
Key performance advantages include a 50% real‑estate reduction versus competing products, on‑state dissipation 1.5‑2× lower, switching times up to ten times faster, and the ability to handle three times the surge for the same area. The arrays are offered in 2‑, 3‑, 4‑, 5‑, 6‑, and 8‑element configurations and in 5‑8.5 V versions, with a power rating of 50 J at 37 °C.
| Real‑estate reduction | 50% compared to competition |
|---|---|
| On‑state dissipation | 1.5‑2× less than competition |
| Switching time (ton) | up to 10× faster than competition |
| Surge handling capability | 3× the surge of competition for same area |
| Power rating | 50 J at 37 °C |
| Available voltage versions | 5 V to 8.5 V |
The array is rated for 50 J of power at 37 °C.
The switching time (ton) is up to ten times faster than competing devices.
It reduces real‑estate by 50% compared with competing products.
Yes, it can handle three times the surge of competing devices for the same physical area.